N-(1-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl)-1-(3-methoxyphenyl)cyclopropanecarboxamide

ID: ALA5200718

PubChem CID: 168291341

Max Phase: Preclinical

Molecular Formula: C19H17FN4O2

Molecular Weight: 352.37

Names and Identifiers

Canonical SMILES:  COc1cccc(C2(C(=O)Nc3ccn(-c4cncc(F)c4)n3)CC2)c1

Standard InChI:  InChI=1S/C19H17FN4O2/c1-26-16-4-2-3-13(9-16)19(6-7-19)18(25)22-17-5-8-24(23-17)15-10-14(20)11-21-12-15/h2-5,8-12H,6-7H2,1H3,(H,22,23,25)

Standard InChI Key:  ONUIADLQEUOOQW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   35.0402   -4.8041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3344   -4.3955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3334   -5.2110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8190   -5.5924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.8179   -6.4119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5259   -6.8209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2356   -6.4114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2328   -5.5888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5241   -5.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9385   -5.1750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6863   -5.5045    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2308   -4.8952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8195   -4.1890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0209   -4.3620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0439   -4.9775    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5217   -4.3146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1865   -3.5693    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.8126   -3.7340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6234   -3.8183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1011   -3.1562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7660   -2.4100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9485   -2.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4744   -2.9929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5257   -7.6380    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   36.9141   -3.2390    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.2489   -3.9844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  8 10  1  0
 12 15  1  0
 15 16  1  0
 16  2  1  0
 16 17  2  0
  2 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  6 24  1  0
 20 25  1  0
 25 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5200718

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 352.37

Molecular Weight (Monoisotopic): 352.1336

AlogP: 3.09

#Rotatable Bonds: 5

Polar Surface Area: 69.04

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.18

CX Basic pKa: 2.39

CX LogP: 3.13

CX LogD: 3.13

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.77

Np Likeness Score: -1.91

References

1. Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, Krueger E, Liang J, Morris M, Nanthakumar S, O'Dowd H, Maltais F, Iyer G, Andreassi J, Boucher C, Considine T, Moody CS, Taylor W, Mohanty AK, Huang Y, Zuccola H, Coll J, Bonanno KC, Gagnon KJ, Gan L, Lu F, Gao H, Chakilam A, Engtrakul J, Song B, Crawford D, Doyle E, Kramer T, Vought B, Phillips J, Kemper R, Sanders M, Swett R, Furey B, Winquist R, Bunnage ME, Jackson KL, Charifson PS, Magavi SS..  (2021)  Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.,  64  (24.0): [PMID:34748351] [10.1021/acs.jmedchem.1c00944]

Source

Source(1):

• Scientific Literature